Literature DB >> 17766100

The effectiveness and safety of syringe vending machines as a component of needle syringe programmes in community settings.

Mofizul Islam1, Alex Wodak, Katherine M Conigrave.   

Abstract

Syringe vending machines (SVMs) have been introduced in Europe and Australasia as part of the effort to increase the availability of sterile needles and syringes to injecting drug users (IDUs). This qualitative review of 14 published and grey literature studies examines whether community-based SVMs as a component of a comprehensive needle syringe programme (NSP) assist to reduce the spread of HIV and other blood-borne viruses amongst IDUs. The available evidence suggests that SVMs increase access to sterile injecting equipment, reduce needle and syringe sharing, and are likely to be cost efficient. SVMs also complement other modes of NSP delivery as they are used by IDUs who are less likely to attend staffed NSPs or pharmacies. If installed and properly maintained in a well-chosen location and with the local community well prepared, SVMs can enhance the temporal and geographical availability of sterile injecting equipment.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17766100     DOI: 10.1016/j.drugpo.2007.07.006

Source DB:  PubMed          Journal:  Int J Drug Policy        ISSN: 0955-3959


  12 in total

1.  Setting foot in private spaces: extending the hepatitis C cascade of care to automatic needle/syringe dispensing machines, a mixed methods study.

Authors:  Heidi Coupland; Charles Henderson; Janice Pritchard-Jones; Shih-Chi Kao; Sinead Sheils; Regina Nagy; Martin O'Donnell; Paul S Haber; Carolyn A Day
Journal:  Harm Reduct J       Date:  2022-05-28

2.  Syringe Service Program Utilization, Barriers, and Preferences for Design in Rural Appalachia: Differences between Men and Women Who Inject Drugs.

Authors:  Kathryn E Lancaster; Hannah L F Cooper; Christopher R Browning; Carlos D Malvestutto; John F P Bridges; April M Young
Journal:  Subst Use Misuse       Date:  2020-08-04       Impact factor: 2.164

3.  Injecting Drug Users Retention in Needle-Exchange Program and its Determinants in Iran Prisons.

Authors:  Mohammad Shahbazi; Marzieh Farnia; Ghobad Moradi; Mohammadreza Karamati; Fatemeh Paknazar; Majid Mirmohammad Khani
Journal:  Int J High Risk Behav Addict       Date:  2015-06-20

4.  Geo-spatial analysis of individual-level needle and syringe coverage in Melbourne, Australia.

Authors:  Daniel O'Keefe; Anna Wilkinson; Campbell Aitken; Paul Dietze
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

5.  Impact of HIV Status Notification on Risk Behaviors among Men Who Inject Drugs in Kermanshah, West of Iran.

Authors:  Alireza Noroozi; Ali Mirzazadeh; Ali Farhoudian; Ahmad Hajebi; Hamid Reza Khankeh; Peter Higgs; Hamid Sharifi; Bahram Armoon; Mehdi Noroozi
Journal:  J Res Health Sci       Date:  2016

6.  Emergency department care for patients who use opioids during the COVID-19 pandemic.

Authors:  Sarah A Weicker; Kelsey A Speed; Elaine Hyshka; May Mrochuk; Brynn Kosteniuk; Kathryn Dong
Journal:  CJEM       Date:  2021-11-24       Impact factor: 2.929

7.  Assessing the role of syringe dispensing machines and mobile van outlets in reaching hard-to-reach and high-risk groups of injecting drug users (IDUs): a review.

Authors:  Md Mofizul Islam; Katherine M Conigrave
Journal:  Harm Reduct J       Date:  2007-10-24

8.  Impact of current and scaled-up levels of hepatitis C prevention and treatment interventions for people who inject drugs in three UK settings-what is required to achieve the WHO's HCV elimination targets?

Authors:  Zoe Ward; Lucy Platt; Sedona Sweeney; Vivian D Hope; Lisa Maher; Sharon Hutchinson; Norah Palmateer; Josie Smith; Noel Craine; Avril Taylor; Natasha Martin; Rachel Ayres; John Dillon; Matthew Hickman; Peter Vickerman
Journal:  Addiction       Date:  2018-05-17       Impact factor: 6.526

9.  Application of data mining techniques and logistic regression to model drug use transition to injection: a case study in drug use treatment centers in Kermanshah Province, Iran.

Authors:  Somayeh Najafi-Ghobadi; Khadijeh Najafi-Ghobadi; Lily Tapak; Abbas Aghaei
Journal:  Subst Abuse Treat Prev Policy       Date:  2019-12-12

10.  Experiences of people with opioid use disorder during the COVID-19 pandemic: A qualitative study.

Authors:  Lexis R Galarneau; Jesse Hilburt; Zoe R O'Neill; Jane A Buxton; Frank X Scheuermeyer; Kathryn Dong; Janusz Kaczorowski; Aaron M Orkin; Skye Pamela Barbic; Misty Bath; Jessica Moe; Isabelle Miles; Dianne Tobin; Sherry Grier; Emma Garrod; Andrew Kestler
Journal:  PLoS One       Date:  2021-07-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.